ISO Technika

  • In Development
  • ::
  • For Investors
  • ::
  • Corporate
  • ::
  • Governance
  • Isotechnika Diagnostics
  • ::
  • Partnerships
Printer Friendly

Isotechnika Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of novel immunosuppressive therapeutics for the treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. In addition to the Company’s drug pipeline, Isotechnika also has diagnostic products.

  • voclosporin
  • TAFA93
  • Information Circular
  • Corporate Overview
  • Corporate Strategy
  • Milestones
  • Helikit ®


Webcast Icon

There are no webcasts at this time. Please see our Archive section to view past presentations.